TokenPost·
Insight Molecular Diagnostics to Report Q3 Results Nov. 16
Consensus estimates put earnings per share at a loss of $0.22, with a reported 35.3% year-over-year increase. Revenue is projected at $240,000, down 7.7%.
More news
- TokenPostTSMC Confirms Employee Data Leak as Sellers Seek 3 Bitcoin
- CryptoPotatoTSMC Confirms Employee Data Leak as Hackers Try to Sell 46,000 Records for Bitcoin
- TokenPostGMX Dollar Vault LPs Can Borrow USDG Against GLV on Morpho
- TokenPostBri-Chem Names CFO Tony Pagnucco as Chief Operating Officer
- TokenPostIM Cannabis Reports $1.65 Million in Q3 Revenue and GAAP EPS of -$6.69
- The DefiantNvidia Approached Arm CEO Haas in Search, FT Reports